Literature DB >> 33924851

Latest Advances of Virology Research Using CRISPR/Cas9-Based Gene-Editing Technology and Its Application to Vaccine Development.

Man Teng1,2, Yongxiu Yao3, Venugopal Nair3, Jun Luo1,2,4.   

Abstract

In recent years, the CRISPR/Cas9-based gene-editing techniques have been well developed and applied widely in several aspects of research in the biological sciences, in many species, including humans, animals, plants, and even in viruses. Modification of the viral genome is crucial for revealing gene function, virus pathogenesis, gene therapy, genetic engineering, and vaccine development. Herein, we have provided a brief review of the different technologies for the modification of the viral genomes. Particularly, we have focused on the recently developed CRISPR/Cas9-based gene-editing system, detailing its origin, functional principles, and touching on its latest achievements in virology research and applications in vaccine development, especially in large DNA viruses of humans and animals. Future prospects of CRISPR/Cas9-based gene-editing technology in virology research, including the potential shortcomings, are also discussed.

Entities:  

Keywords:  CRISPR/Cas9; gene editing; gene function; vaccine; virus

Year:  2021        PMID: 33924851     DOI: 10.3390/v13050779

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  119 in total

Review 1.  CRISPR/Cas system and its role in phage-bacteria interactions.

Authors:  Hélène Deveau; Josiane E Garneau; Sylvain Moineau
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

2.  Construction of large DNA segments in Escherichia coli.

Authors:  M O'Connor; M Peifer; W Bender
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

3.  Live attenuated pseudorabies virus developed using the CRISPR/Cas9 system.

Authors:  Yan-Dong Tang; Ji-Ting Liu; Tong-Yun Wang; Tong-Qing An; Ming-Xia Sun; Shu-Jie Wang; Qiong-Qiong Fang; Lin-Lin Hou; Zhi-Jun Tian; Xue-Hui Cai
Journal:  Virus Res       Date:  2016-09-13       Impact factor: 3.303

4.  Efficiently editing the vaccinia virus genome by using the CRISPR-Cas9 system.

Authors:  Ming Yuan; Wensheng Zhang; Jun Wang; Chadwan Al Yaghchi; Jahangir Ahmed; Louisa Chard; Nick R Lemoine; Yaohe Wang
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

5.  The gRNA-miRNA-gRNA Ternary Cassette Combining CRISPR/Cas9 with RNAi Approach Strongly Inhibits Hepatitis B Virus Replication.

Authors:  Jie Wang; Ran Chen; Ruiyang Zhang; Shanlong Ding; Tianying Zhang; Quan Yuan; Guiwen Guan; Xiangmei Chen; Ting Zhang; Hui Zhuang; Frederick Nunes; Timothy Block; Shuang Liu; Zhongping Duan; Ningshao Xia; Zhongwei Xu; Fengmin Lu
Journal:  Theranostics       Date:  2017-07-22       Impact factor: 11.556

6.  A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape.

Authors:  Robert Jan Lebbink; Dorien C M de Jong; Femke Wolters; Elisabeth M Kruse; Petra M van Ham; Emmanuel J H J Wiertz; Monique Nijhuis
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

7.  Engineering large viral DNA genomes using the CRISPR-Cas9 system.

Authors:  Tadahiro Suenaga; Masako Kohyama; Kouyuki Hirayasu; Hisashi Arase
Journal:  Microbiol Immunol       Date:  2014-09       Impact factor: 1.955

8.  Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing.

Authors:  Yu-Chan Yang; Yu-Hsiang Chen; Jia-Horng Kao; Chi Ching; I-Jung Liu; Chih-Chiang Wang; Cheng-Hsueh Tsai; Fang-Yi Wu; Chun-Jen Liu; Pei-Jer Chen; Ding-Shinn Chen; Hung-Chih Yang
Journal:  Mol Ther Nucleic Acids       Date:  2020-03-19       Impact factor: 8.886

9.  Efficient Mutagenesis of Marek's Disease Virus-Encoded microRNAs Using a CRISPR/Cas9-Based Gene Editing System.

Authors:  Jun Luo; Man Teng; Xusheng Zai; Na Tang; Yaoyao Zhang; Ahmedali Mandviwala; Vishwanatha R A P Reddy; Susan Baigent; Yongxiu Yao; Venugopal Nair
Journal:  Viruses       Date:  2020-04-20       Impact factor: 5.048

10.  Simultaneous Deletion of Virulence Factors and Insertion of Antigens into the Infectious Laryngotracheitis Virus Using NHEJ-CRISPR/Cas9 and Cre-Lox System for Construction of a Stable Vaccine Vector.

Authors:  Mustafa Ozan Atasoy; Mohammed A Rohaim; Muhammad Munir
Journal:  Vaccines (Basel)       Date:  2019-12-05
View more
  6 in total

1.  CRISPR/Cas9 Editing of Duck Enteritis Virus Genome for the Construction of a Recombinant Vaccine Vector Expressing ompH Gene of Pasteurella multocida in Two Novel Insertion Sites.

Authors:  Nisachon Apinda; Yongxiu Yao; Yaoyao Zhang; Vishwanatha R A P Reddy; Pengxiang Chang; Venugopal Nair; Nattawooti Sthitmatee
Journal:  Vaccines (Basel)       Date:  2022-04-27

2.  Simultaneous Protective Immune Responses of Ducks against Duck Plague and Fowl Cholera by Recombinant Duck Enteritis Virus Vector Expressing Pasteurella multocida OmpH Gene.

Authors:  Nisachon Apinda; Anucha Muenthaisong; Paweena Chomjit; Kanokwan Sangkakam; Boondarika Nambooppha; Amarin Rittipornlertrak; Pongpisid Koonyosying; Yongxiu Yao; Venugopal Nair; Nattawooti Sthitmatee
Journal:  Vaccines (Basel)       Date:  2022-08-19

3.  Pathogenicity and Pathotype Analysis of Henan Isolates of Marek's Disease Virus Reveal Long-Term Circulation of Highly Virulent MDV Variant in China.

Authors:  Man Teng; Lu-Ping Zheng; Hui-Zhen Li; Sheng-Ming Ma; Zhi-Jian Zhu; Shu-Jun Chai; Yongxiu Yao; Venugopal Nair; Gai-Ping Zhang; Jun Luo
Journal:  Viruses       Date:  2022-07-27       Impact factor: 5.818

Review 4.  The Application of the CRISPR-Cas System in Antibiotic Resistance.

Authors:  Shuan Tao; Huimin Chen; Na Li; Wei Liang
Journal:  Infect Drug Resist       Date:  2022-08-02       Impact factor: 4.177

Review 5.  In vivo Delivery Tools for Clustered Regularly Interspaced Short Palindromic Repeat/Associated Protein 9-Mediated Inhibition of Hepatitis B Virus Infection: An Update.

Authors:  Mohammad Enamul Hoque Kayesh; Md Abul Hashem; Michinori Kohara; Kyoko Tsukiyama-Kohara
Journal:  Front Microbiol       Date:  2022-07-01       Impact factor: 6.064

6.  A New Strategy for Efficient Screening and Identification of Monoclonal Antibodies against Oncogenic Avian Herpesvirus Utilizing CRISPR/Cas9-Based Gene-Editing Technology.

Authors:  Man Teng; Zi-Yu Zhou; Yongxiu Yao; Venugopal Nair; Gai-Ping Zhang; Jun Luo
Journal:  Viruses       Date:  2022-09-14       Impact factor: 5.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.